Rajesh B Parekh - Net Worth and Insider Trading
Rajesh B Parekh Net Worth
The estimated net worth of Rajesh B Parekh is at least $109,440 dollars as of 2024-09-20. Rajesh B Parekh is the Director of Celldex Therapeutics Inc and owns about 2,667 shares of Celldex Therapeutics Inc (CLDX) stock worth over $109,440. Details can be seen in Rajesh B Parekh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rajesh B Parekh has not made any transactions after 2010-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rajesh B Parekh
Rajesh B Parekh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rajesh B Parekh owns 3 companies in total, including Celldex Therapeutics Inc (CLDX) , Eloxx Pharmaceuticals Inc (ELOX) , and Aura Biosciences Inc (AURA) .
Click here to see the complete history of Rajesh B Parekh’s form 4 insider trades.
Insider Ownership Summary of Rajesh B Parekh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2010-09-13 | director |
| ELOX | Eloxx Pharmaceuticals Inc | 2021-05-13 | director |
| AURA | Aura Biosciences Inc | 2021-10-28 | director |
Rajesh B Parekh Latest Holdings Summary
Rajesh B Parekh currently owns a total of 1 stock. Rajesh B Parekh owns 2,667 shares of Celldex Therapeutics Inc (CLDX) as of September 13, 2010, with a value of $109,440.
Latest Holdings of Rajesh B Parekh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2010-09-13 | 2,667 | 41.04 | 109,440 |
Holding Weightings of Rajesh B Parekh
Rajesh B Parekh Form 4 Trading Tracker
According to the SEC Form 4 filings, Rajesh B Parekh has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the acquisition of 2,667 shares on September 13, 2010, which cost Rajesh B Parekh around $149,200.
Insider Trading History of Rajesh B Parekh
- 1
Rajesh B Parekh Trading Performance
GuruFocus tracks the stock performance after each of Rajesh B Parekh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rajesh B Parekh is 4.82%. GuruFocus also compares Rajesh B Parekh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rajesh B Parekh within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rajesh B Parekh's insider trading performs compared to the benchmark.
Performance of Rajesh B Parekh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.69 | | | | | |
| Relative Return to S&P 500(%) | 7.68 | | | | | |
Rajesh B Parekh Ownership Network
Rajesh B Parekh Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Rajesh B Parekh is the director of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include SVP & Chief Product Dev Officer Elizabeth Crowley , SVP and CFO Samuel Bates Martin , and SVP & Chief Medical Officer Diane C. Young .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Rajesh B Parekh made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,560 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Rajesh B Parekh Mailing Address
Above is the net worth, insider trading, and ownership report for Rajesh B Parekh. You might contact Rajesh B Parekh via mailing address: Alchester House, Langford Lane, North Wendlebury, Bichester X0 Ox6 Ons.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
